glp 1 agonists and depression GLP-1 Receptor Research to Treat Overeating and Substance Use Disorders Exploring the Side Effects of
Description
These medications are now recommended for patients with type 2 diabetes and chronic kidney disease to reduce cardiovascular risk and protect renal function
Overall, while pharmacovigilance reports have described a range of psychiatric symptoms, real-world evidence to date does not support an increased risk of suicidality with GLP-1 RAs in patients with type 2 diabetes
As a result, the brain releases more of the hunger hormone ghrelin and dials down leptin, one of the hormones that signals fullness and energy sufficiency
British Journal of Nutrition , 103
& Gossop, M
Liraglutide (Victoza) injection [package insert]
